H-DL-Homopro-OH

H-DL-Homopro-OH is a DL-labeled homoproline derivative presented as a free amino acid bearing an amino group and a carboxyl group, with a side chain that forms a pyrrolidine ring bearing an extra methylene relative to proline (homoproline framework). The molecule contains the N-H (hydrogen) form on the amino nitrogen and exists as a racemic (DL) mixture, with no additional protecting groups or ester/amide modifications indicated by the name. As a free amino acid building block, it is used in peptide and amino acid derivative synthesis and in labeling or structural studies where a homoproline residue analog is required to probe conformational effects in peptide backbones.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP27188

CAS No:535-75-1

Synonyms/Alias:piperidine-2-carboxylicacid;DL-Pipecolinicacid;Pipecolicacid;Pipecolinicacid;535-75-1;2-PIPERIDINECARBOXYLICACID;Homoproline;pipecolate;Dihydrobaikiane;Piperolinicacid;4043-87-2;DL-Pipecolicacid;Hexahydropicolinicacid;DL-Homoproline;Acidepipecolique;2-Carboxypiperidine;Pipecolicacid,L-;Pipecolinate;Piperolinate;a-Pipecolinate;Pipecolicacidfreebase;DL-Pipecolinate;L-PipecolicAcid;(+/-)-Pipecolicacid;.alpha.-Pipecolinicacid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C6H11NO2
M.W/Mr.
129.16

H-DL-Homopro-OH is a DL mixture of homoproline-derived amino acid material featuring a secondary amine and a carboxylic acid within a constrained pyrrolidine ring framework, where the stereochemical outcome is racemic at the chiral center. The molecule is present in a protected/functionalized form consistent with an amino acid building block designation (H- at the nitrogen and a free carboxyl group as indicated by the hydroxyl-terminated carboxylic acid, "-OH"), enabling predictable coupling chemistry while maintaining the cyclic side-chain geometry characteristic of homoproline analogs. The ring constraint and the amino acid functionality together support formation of amide bonds under standard peptide coupling conditions and enable downstream transformations of the carboxyl group for esterification, activation, or conversion to protected derivatives. Racemic composition makes it suitable for method development, screening, and intermediate preparation where stereochemical separation may be performed later, while the structural constraint supports incorporation into peptide-like scaffolds and constrained peptidomimetic motifs.

1. Peptide Synthesis

H-DL-Homopro-OH serves as a homoproline-type amino acid component for peptide building block preparation in synthetic peptide workflows. The carboxylic acid and secondary amine functionality support amide bond formation after appropriate activation of the acid, enabling incorporation into linear peptides and cyclic or conformationally constrained sequences. The pyrrolidine ring geometry can influence backbone torsion angles and side-chain presentation, which can be leveraged during peptide coupling chemistry and subsequent deprotection or functional group interconversions. Racemic stereochemistry allows rapid access to homoproline-containing analog libraries for method development and structure-focused synthesis, with downstream resolution possible when enantiopure derivatives are required.

2. Peptidomimetics Construction

H-DL-Homopro-OH is suitable for peptidomimetic construction where constrained ring topology is used to modulate conformational preferences. The cyclic secondary amine and carboxylic acid enable conversion into amide-linked fragments, lactam-forming intermediates, or side-chain functionalized analogs that preserve the homoproline-like spatial arrangement. Carboxyl-group derivatization supports downstream scaffold elaboration such as coupling to heterocycles, attachment of linkers for SAR studies, or generation of acid-to-activated-ester intermediates for iterative synthesis. DL availability supports combinatorial peptidomimetic library generation and intermediate preparation for later stereochemical refinement.

3. Chiral Building Block Development

H-DL-Homopro-OH functions as a chiral amino acid intermediate precursor in workflows that require racemate handling prior to enantiomer separation. The defined stereocenter within the homoproline framework provides a clear target for chiral resolution strategies, while the free carboxylic acid supports formation of diastereomeric salts or derivatization intermediates that can be separated analytically or preparatively. The nitrogen-bearing amino acid motif can be further protected or transformed to enable controlled stereochemical retention during downstream coupling and functional group manipulations. Racemic starting material can also be used to evaluate stereochemical effects in synthetic methodology development before committing to enantiopure building blocks.

4. Pharmaceutical Intermediate Preparation

H-DL-Homopro-OH can be applied in pharmaceutical intermediate preparation where amino acid-derived fragments are used to assemble medicinal chemistry scaffolds. The carboxylic acid group enables conversion to activated acid derivatives suitable for coupling into amide-containing structures, while the cyclic secondary amine can participate in protected amine strategies to control chemoselectivity during multi-step synthesis. The constrained homoproline ring can be incorporated into linker regions or scaffold cores to tune three-dimensional shape in structure-activity relationship studies. DL material is particularly relevant for process chemistry intermediate generation and for supplying feedstocks to downstream enantiomer-enrichment steps when required by final scaffold design.

5. Analytical Research Standards

H-DL-Homopro-OH is suitable for analytical research and method development as an amino acid reference material for chromatographic and mass spectrometric characterization of homoproline-containing derivatives. The presence of a defined amino acid functional set, including a carboxylic acid and ring-constrained amine, supports derivatization approaches used to generate detectable derivatives for LC-MS or GC-MS workflows. Racemic composition can be used to validate retention behavior, calibration curves for total content, and fragmentation patterns for peptide hydrolysate analyses. Downstream conversion to esters, amides, or labeled derivatives can further support analytical standard preparation for monitoring peptide coupling, deprotection completeness, and intermediate purity in synthetic pipelines.

Size
25 g;100 g;
InChI
1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)
InChI Key
HXEACLLIILLPRG-UHFFFAOYSA-N
Canonical SMILES
C1CCNC(C1)C(=O)O

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Nucleic Acids SynthesiscGMP Peptide ServicePeptide Analysis ServicesPeptide Modification ServicesPeptide Synthesis ServicesEpitope Mapping ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers